{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:14:44Z","timestamp":1791360884627,"version":"4.3.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY022077"],"award-info":[{"award-number":["EY022077"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY026177"],"award-info":[{"award-number":["EY026177"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY028616"],"award-info":[{"award-number":["EY028616"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY016242"],"award-info":[{"award-number":["EY016242"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Glaucoma is a leading neurodegenerative disease affecting over 70 million individuals worldwide. Early pathological events of axonal degeneration and retinopathy in response to elevated intraocular pressure (IOP) are limited and not well-defined due to the lack of appropriate animal models that faithfully replicate all the phenotypes of primary open angle glaucoma (POAG), the most common form of glaucoma. Glucocorticoid (GC)-induced ocular hypertension (OHT) and its associated iatrogenic open-angle glaucoma share many features with POAG. Here, we characterized a novel mouse model of GC-induced OHT for glaucomatous neurodegeneration and further explored early pathological events of axonal degeneration in response to elevated IOP.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>C57BL\/6\u2009J mice were periocularly injected with either vehicle or the potent GC, dexamethasone 21-acetate (Dex) once a week for 10\u2009weeks. Glaucoma phenotypes including IOP, outflow facility, structural and functional loss of retinal ganglion cells (RGCs), optic nerve (ON) degeneration, gliosis, and anterograde axonal transport deficits were examined at various stages of OHT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Prolonged treatment with Dex leads to glaucoma in mice similar to POAG patients including IOP elevation due to reduced outflow facility and dysfunction of trabecular meshwork, progressive ON degeneration and structural and functional loss of RGCs. Lowering of IOP rescued Dex-induced ON degeneration and RGC loss, suggesting that glaucomatous neurodegeneration is IOP dependent. Also, Dex-induced neurodegeneration was associated with activation of astrocytes, axonal transport deficits, ON demyelination, mitochondrial accumulation and immune cell infiltration in the optic nerve head (ONH) region. Our studies further show that ON degeneration precedes structural and functional loss of RGCs in Dex-treated mice. Axonal damage and transport deficits initiate at the ONH and progress toward the distal end of ON and target regions in the brain (i.e. superior colliculus). Most of anterograde transport was preserved during initial stages of axonal degeneration (30% loss) and complete transport deficits were only observed at the ONH during later stages of severe axonal degeneration (50% loss).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These findings indicate that ON degeneration and transport deficits at the ONH precede RGC structural and functional loss and provide a new potential therapeutic window for rescuing neuronal loss and restoring health of damaged axons in glaucoma.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13024-020-00400-9","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T15:03:49Z","timestamp":1598540629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Prabhavathi","family":"Maddineni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh B.","family":"Kasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinkal D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Cameron","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kiehlbauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbot F.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7823-2595","authenticated-orcid":false,"given":"Gulab S.","family":"Zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"11","key":"400_CR1","first-page":"887","volume":"82","author":"S Kingman","year":"2004","unstructured":"Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82(11):887\u20138.","journal-title":"Bull World Health Organ"},{"issue":"11","key":"400_CR2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology."},{"issue":"3","key":"400_CR3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"400_CR4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.eye.6701973","volume":"19","author":"A Foster","year":"2005","unstructured":"Foster A, Resnikoff S. The impact of vision 2020 on global blindness. Eye (Lond). 2005;19(10):1133\u20135.","journal-title":"Eye (Lond)"},{"issue":"1","key":"400_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","volume":"100","author":"VV Kapetanakis","year":"2016","unstructured":"Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016;100(1):86\u201393.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"400_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","year":"1998","unstructured":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-tension Glaucoma study group. Am J Ophthalmol. 1998;126(4):487\u201397.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"400_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","year":"1998","unstructured":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):498\u2013505.","journal-title":"Am J Ophthalmol"},{"issue":"9975","key":"400_CR8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385(9975):1295\u2013304.","journal-title":"Lancet."},{"key":"400_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","volume":"4","author":"M Goel","year":"2010","unstructured":"Goel M, Picciani RG, Lee RK, Bhattacharya SK. Aqueous humor dynamics: a review. Open Ophthalmol J. 2010;4:52\u20139.","journal-title":"Open Ophthalmol J"},{"issue":"5","key":"400_CR10","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1167\/iovs.15-16744","volume":"56","author":"U Roy Chowdhury","year":"2015","unstructured":"Roy Chowdhury U, Hann CR, Stamer WD, Fautsch MP. Aqueous humor outflow: dynamics and disease. Invest Ophthalmol Vis Sci. 2015;56(5):2993\u20133003.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"400_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","volume":"360","author":"YH Kwon","year":"2009","unstructured":"Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009;360(11):1113\u201324.","journal-title":"N Engl J Med"},{"issue":"9422","key":"400_CR12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711\u201320.","journal-title":"Lancet."},{"issue":"6","key":"400_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/exer.1993.1085","volume":"56","author":"JW Rohen","year":"1993","unstructured":"Rohen JW, Lutjen-Drecoll E, Flugel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res. 1993;56(6):683\u201392.","journal-title":"Exp Eye Res"},{"issue":"4","key":"400_CR14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.exer.2008.01.013","volume":"86","author":"TS Acott","year":"2008","unstructured":"Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86(4):543\u201361.","journal-title":"Exp Eye Res"},{"issue":"12","key":"400_CR15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0161-6420(95)30797-X","volume":"102","author":"SV Araujo","year":"1995","unstructured":"Araujo SV, Spaeth GL, Roth SM, Starita RJ. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology. 1995;102(12):1753\u20139.","journal-title":"Ophthalmology."},{"issue":"12","key":"400_CR16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0161-6420(95)30796-8","volume":"102","author":"K Nouri-Mahdavi","year":"1995","unstructured":"Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology. 1995;102(12):1760\u20139.","journal-title":"Ophthalmology."},{"issue":"2","key":"400_CR17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","volume":"18","author":"N Gupta","year":"2007","unstructured":"Gupta N, Yucel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18(2):110\u20134.","journal-title":"Curr Opin Ophthalmol"},{"key":"400_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2015.06.002","volume":"141","author":"DR Overby","year":"2015","unstructured":"Overby DR, Clark AF. Animal models of glucocorticoid-induced glaucoma. Exp Eye Res. 2015;141:15\u201322.","journal-title":"Exp Eye Res"},{"issue":"10","key":"400_CR19","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1167\/iovs.03-0137","volume":"44","author":"M Aihara","year":"2003","unstructured":"Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44(10):4314\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"400_CR20","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1167\/iovs.03-0138","volume":"44","author":"F Mabuchi","year":"2003","unstructured":"Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN. Optic nerve damage in experimental mouse ocular hypertension. Invest Ophthalmol Vis Sci. 2003;44(10):4321\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"400_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1167\/iovs.09-3947","volume":"51","author":"RM Sappington","year":"2010","unstructured":"Sappington RM, Carlson BJ, Crish SD, Calkins DJ. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010;51(1):207\u201316.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"400_CR22","doi-asserted-by":"crossref","unstructured":"Zhang J, Li L, Huang H, Fang F, Webber HC, Zhuang P, et al. Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse. Elife. 2019;8.","DOI":"10.7554\/eLife.45881"},{"issue":"6","key":"400_CR23","first-page":"951","volume":"39","author":"SW John","year":"1998","unstructured":"John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA\/2J mice. Invest Ophthalmol Vis Sci. 1998;39(6):951\u201362.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"400_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ng794","volume":"30","author":"MG Anderson","year":"2002","unstructured":"Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA\/2J mice. Nat Genet. 2002;30(1):81\u20135.","journal-title":"Nat Genet"},{"key":"400_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archopht.1963.00960050502012","volume":"70","author":"B Becker","year":"1963","unstructured":"Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500\u20137.","journal-title":"Arch Ophthalmol"},{"key":"400_CR26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. Ii. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"400_CR27","first-page":"163","volume":"17","author":"R Jones 3rd","year":"2006","unstructured":"Jones R 3rd, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17(2):163\u20137.","journal-title":"Curr Opin Ophthalmol"},{"key":"400_CR28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. the effect of dexamethasone in the Normal eye. Arch Ophthalmol. 1963;70:482\u201391.","journal-title":"Arch Ophthalmol"},{"key":"400_CR29","first-page":"198","volume":"4","author":"B Becker","year":"1965","unstructured":"Becker B. Intraocular Pressure Response to Topical Corticosteroids. Investig Ophthalmol. 1965;4:198\u2013205.","journal-title":"Investig Ophthalmol"},{"issue":"4","key":"400_CR30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.exer.2008.10.004","volume":"88","author":"AF Clark","year":"2009","unstructured":"Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752\u20139.","journal-title":"Exp Eye Res"},{"issue":"5","key":"400_CR31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1350-9462(98)00035-4","volume":"18","author":"RJ Wordinger","year":"1999","unstructured":"Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18(5):629\u201367.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"400_CR32","doi-asserted-by":"crossref","first-page":"14951","DOI":"10.1038\/s41598-017-14938-0","volume":"7","author":"RB Kasetti","year":"2017","unstructured":"Kasetti RB, Maddineni P, Millar JC, Clark AF, Zode GS. Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork. Sci Rep. 2017;7(1):14951.","journal-title":"Sci Rep"},{"issue":"25","key":"400_CR33","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1074\/jbc.RA118.002540","volume":"293","author":"RB Kasetti","year":"2018","unstructured":"Kasetti RB, Maddineni P, Patel PD, Searby C, Sheffield VC, Zode GS. Transforming growth factor beta2 (TGFbeta2) signaling plays a key role in glucocorticoid-induced ocular hypertension. J Biol Chem. 2018;293(25):9854\u201368.","journal-title":"J Biol Chem"},{"issue":"2","key":"400_CR34","first-page":"478","volume":"36","author":"AF Clark","year":"1995","unstructured":"Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36(2):478\u201389.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"400_CR35","first-page":"281","volume":"35","author":"AF Clark","year":"1994","unstructured":"Clark AF, Wilson K, McCartney MD, Miggans ST, Kunkle M, Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35(1):281\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"400_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2006.09.022","volume":"84","author":"X Zhang","year":"2007","unstructured":"Zhang X, Ognibene CM, Clark AF, Yorio T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta. Exp Eye Res. 2007;84(2):275\u201384.","journal-title":"Exp Eye Res"},{"issue":"12","key":"400_CR37","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1167\/iovs.10-5430","volume":"51","author":"NA Whitlock","year":"2010","unstructured":"Whitlock NA, McKnight B, Corcoran KN, Rodriguez LA, Rice DS. Increased intraocular pressure in mice treated with dexamethasone. Invest Ophthalmol Vis Sci. 2010;51(12):6496\u2013503.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"400_CR38","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI69774","volume":"124","author":"GS Zode","year":"2014","unstructured":"Zode GS, Sharma AB, Lin X, Searby CC, Bugge K, Kim GH, et al. Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma. J Clin Invest. 2014;124(5):1956\u201365.","journal-title":"J Clin Invest"},{"issue":"5","key":"400_CR39","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.1814889116","volume":"116","author":"G Li","year":"2019","unstructured":"Li G, Lee C, Agrahari V, Wang K, Navarro I, Sherwood JM, et al. In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model. Proc Natl Acad Sci U S A. 2019;116(5):1714\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"400_CR40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajpath.2016.12.003","volume":"187","author":"GC Patel","year":"2017","unstructured":"Patel GC, Phan TN, Maddineni P, Kasetti RB, Millar JC, Clark AF, et al. Dexamethasone-induced ocular hypertension in mice: effects of Myocilin and route of administration. Am J Pathol. 2017;187(4):713\u201323.","journal-title":"Am J Pathol"},{"issue":"9","key":"400_CR41","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","volume":"121","author":"GS Zode","year":"2011","unstructured":"Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, et al. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest. 2011;121(9):3542\u201353.","journal-title":"J Clin Invest"},{"issue":"2","key":"400_CR42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1167\/iovs.10-6069","volume":"52","author":"JC Millar","year":"2011","unstructured":"Millar JC, Clark AF, Pang IH. Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion. Invest Ophthalmol Vis Sci. 2011;52(2):685\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"400_CR43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-7407-8_12","volume":"1695","author":"P Maddineni","year":"2018","unstructured":"Maddineni P, Kasetti RB, Zode GS. Methods for analyzing endoplasmic reticulum stress in the trabecular meshwork of Glaucoma models. Methods Mol Biol. 2018;1695:121\u201334.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"400_CR44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"400_CR45","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1167\/iovs.14-13943","volume":"55","author":"TH Chou","year":"2014","unstructured":"Chou TH, Bohorquez J, Toft-Nielsen J, Ozdamar O, Porciatti V. Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode. Invest Ophthalmol Vis Sci. 2014;55(4):2469\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"400_CR46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exer.2010.08.005","volume":"93","author":"JC Morrison","year":"2011","unstructured":"Morrison JC, Cepurna Ying Guo WO, Johnson EC. Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp Eye Res. 2011;93(2):156\u201364.","journal-title":"Exp Eye Res"},{"issue":"1","key":"400_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archopht.1981.03930010139020","volume":"99","author":"HA Quigley","year":"1981","unstructured":"Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981;99(1):137\u201343.","journal-title":"Arch Ophthalmol"},{"key":"400_CR48","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","volume":"2","author":"RN Weinreb","year":"2016","unstructured":"Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nat Rev Dis Primers. 2016;2:16067.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"400_CR49","first-page":"137","volume":"19","author":"HA Quigley","year":"1980","unstructured":"Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. 1980;19(2):137\u201352.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"400_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1350-9462(99)00017-8","volume":"19","author":"MR Hernandez","year":"2000","unstructured":"Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res. 2000;19(3):297\u2013321.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"400_CR51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00175926","volume":"230","author":"T Fukuchi","year":"1992","unstructured":"Fukuchi T, Sawaguchi S, Hara H, Shirakashi M, Iwata K. Extracellular matrix changes of the optic nerve lamina cribrosa in monkey eyes with experimentally chronic glaucoma. Graefes Arch Clin Exp Ophthalmol. 1992;230(5):421\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"400_CR52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1073858403253460","volume":"9","author":"AH Neufeld","year":"2003","unstructured":"Neufeld AH, Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist. 2003;9(6):485\u201395.","journal-title":"Neuroscientist."},{"key":"400_CR53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exer.2017.02.006","volume":"157","author":"ER Tamm","year":"2017","unstructured":"Tamm ER, Ethier CR, Lasker IIA. Glaucomatous Neurodegeneration P. biological aspects of axonal damage in glaucoma: a brief review. Exp Eye Res. 2017;157:5\u201312.","journal-title":"Exp Eye Res"},{"issue":"7","key":"400_CR54","first-page":"640","volume":"16","author":"HA Quigley","year":"1977","unstructured":"Quigley HA, Anderson DR. Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Invest Ophthalmol Vis Sci. 1977;16(7):640\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"400_CR55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.200706181","volume":"179","author":"GR Howell","year":"2007","unstructured":"Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma. J Cell Biol. 2007;179(7):1523\u201337.","journal-title":"J Cell Biol"},{"issue":"11","key":"400_CR56","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1073\/pnas.0913141107","volume":"107","author":"SD Crish","year":"2010","unstructured":"Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107(11):5196\u2013201.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"400_CR57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.eye.6702474","volume":"22","author":"R Sihota","year":"2008","unstructured":"Sihota R, Konkal VL, Dada T, Agarwal HC, Singh R. Prospective, long-term evaluation of steroid-induced glaucoma. Eye (Lond). 2008;22(1):26\u201330.","journal-title":"Eye (Lond)."},{"key":"400_CR58","doi-asserted-by":"crossref","first-page":"6135795","DOI":"10.1155\/2019\/6135795","volume":"2019","author":"I Bollaerts","year":"2019","unstructured":"Bollaerts I, Van Houcke J, Beckers A, Lemmens K, Vanhunsel S, De Groef L, et al. Prior exposure to Immunosuppressors sensitizes retinal microglia and accelerates optic nerve regeneration in Zebrafish. Mediat Inflamm. 2019;2019:6135795.","journal-title":"Mediat Inflamm"},{"issue":"7","key":"400_CR59","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1167\/iovs.06-1282","volume":"48","author":"EC Johnson","year":"2007","unstructured":"Johnson EC, Jia L, Cepurna WO, Doser TA, Morrison JC. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2007;48(7):3161\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"400_CR60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0079-6123(08)01125-4","volume":"173","author":"MR Hernandez","year":"2008","unstructured":"Hernandez MR, Miao H, Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog Brain Res. 2008;173:353\u201373.","journal-title":"Prog Brain Res"},{"issue":"2","key":"400_CR61","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1167\/iovs.16-20571","volume":"58","author":"R Wang","year":"2017","unstructured":"Wang R, Seifert P, Jakobs TC. Astrocytes in the optic nerve head of glaucomatous mice display a characteristic reactive phenotype. Invest Ophthalmol Vis Sci. 2017;58(2):924\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"400_CR62","doi-asserted-by":"crossref","first-page":"E3839","DOI":"10.1073\/pnas.1608769114","volume":"114","author":"JM Harder","year":"2017","unstructured":"Harder JM, Braine CE, Williams PA, Zhu X, MacNicoll KH, Sousa GL, et al. Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective. Proc Natl Acad Sci U S A. 2017;114(19):E3839\u2013E48.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"400_CR63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-018-0303-3","volume":"14","author":"PA Williams","year":"2019","unstructured":"Williams PA, Braine CE, Kizhatil K, Foxworth NE, Tolman NG, Harder JM, et al. Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA\/2J glaucoma. Mol Neurodegener. 2019;14(1):6.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"400_CR64","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.4443-07.2008","volume":"28","author":"BP Buckingham","year":"2008","unstructured":"Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28(11):2735\u201344.","journal-title":"J Neurosci"},{"key":"400_CR65","first-page":"290","volume":"8","author":"CM Dengler-Crish","year":"2014","unstructured":"Dengler-Crish CM, Smith MA, Inman DM, Wilson GN, Young JW, Crish SD. Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA\/2J mouse model of glaucoma. Front Neurosci. 2014;8:290.","journal-title":"Front Neurosci"},{"issue":"4","key":"400_CR66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1172\/JCI61135","volume":"122","author":"GR Howell","year":"2012","unstructured":"Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, Sousa GL, et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest. 2012;122(4):1246\u201361.","journal-title":"J Clin Invest"},{"issue":"6","key":"400_CR67","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1523\/JNEUROSCI.1419-14.2015","volume":"35","author":"RN El-Danaf","year":"2015","unstructured":"El-Danaf RN, Huberman AD. Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types. J Neurosci. 2015;35(6):2329\u201343.","journal-title":"J Neurosci"},{"issue":"10","key":"400_CR68","doi-asserted-by":"crossref","first-page":"E2393","DOI":"10.1073\/pnas.1714888115","volume":"115","author":"ML Risner","year":"2018","unstructured":"Risner ML, Pasini S, Cooper ML, Lambert WS, Calkins DJ. Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma. Proc Natl Acad Sci U S A. 2018;115(10):E2393\u2013E402.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"400_CR69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1083\/jcb.200506099","volume":"171","author":"TC Jakobs","year":"2005","unstructured":"Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA\/2J mice. J Cell Biol. 2005;171(2):313\u201325.","journal-title":"J Cell Biol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-020-00400-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:23:08Z","timestamp":1630023788000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-020-00400-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/s13024-020-00400-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures used in this study were performed in accordance with and adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and the University of North Texas Health Science Center (UNTHSC) Institutional Animal Care and Use Committee (IACUC) Regulations and Guidelines (Protocol #: IACUC-2018-0032).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}